Precision Preoperative Embolization of Pelvic Tumors to Improve Surgical Outcomes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-02-01

Study Completion Date

2024-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main purpose of this study is to assess the efficacy of precision preoperative embolization in decreasing operative blood loss, reducing surgical complications in pelvic tumor surgery. Furthermore the study aims at describing the vascularity in a series of pelvic tumors, and to correlate this with perioperative blood loss.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Follow-up of Mesh/Native Tissue Complications Study(Part I)

NCT03620565

Pelvic Floor

UNKNOWN

Prevention of Pelvic Lymphocele by Floseal During Pelvic Lymphadenectomy for Gynecologic Cancer

NCT01974193

Gynecologic Cancer

UNKNOWN PHASE3

An Analysis Into the Cause and Preventional Method of Thromboembolic Disease in Gynecological Surgery

NCT03644992

Thromboembolic Disease Gynecological Surgery

UNKNOWN

Thromboprophylaxis After Surgery for Gynecologic Malignancy in China

NCT02935530

Gynecologic Neoplasms Venous Thromboembolism Low Molecular Weight Heparin +1 more

COMPLETED PHASE3

Risk-Reducing Surgeries for Hereditary Ovarian Cancer

NCT03294343

Hereditary Breast and Ovarian Cancer Syndrome Colorectal Neoplasms, Hereditary Nonpolyposis Ovariectomy +1 more

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The main purpose of this study is to assess the efficacy of precision preoperative embolization in decreasing operative blood loss, reducing surgical complications in pelvic tumor surgery，which including poor wound healing，nerve injury，and pelvic organs dysfunction. Furthermore the study aims at describing the vascularity in a series of pelvic tumors,which contains four grade：poor，moderate，rich and abundant and to correlate this with perioperative blood loss.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Embolization Pelvic Tumor

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Precision preoperative embolization

60 patients with pelvic tumors will undergo arteriography and receive transcatheter arterial embolization of pelvic tumors 0-24 hours prior to surgery.

Group Type EXPERIMENTAL

Arteriography and precision preoperative embolization

Intervention Type PROCEDURE

Arteriography and transcatheter arterial embolization of pelvic tumors 0-24 hours prior to surgery.

Control group

60 patients with pelvic tumors will undergo arteriography and without transcatheter arterial embolization of pelvic tumors prior to surgery.

Group Type ACTIVE_COMPARATOR

Arteriography

Intervention Type PROCEDURE

Arteriography of pelvic tumors 0-24 hours prior to surgery.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Arteriography and precision preoperative embolization

Arteriography and transcatheter arterial embolization of pelvic tumors 0-24 hours prior to surgery.

Intervention Type PROCEDURE

Arteriography

Arteriography of pelvic tumors 0-24 hours prior to surgery.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Transcatheter arterial embolization Therapeutic angiography Selective arterial embolization

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Primary or metastatic pelvic tumor
* Confirmed by contrast-enhanced magnetic resonance imaging (MRI) or computed tomography (CT) of the pelvic
* Planned surgical resection

Exclusion Criteria

* Contrast medium allergy
* Uncontrolled or concurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No